Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Guangzhou Fermion Technology patents new CDK7 inhibitors

April 20, 2022

Plexium compound shows the promise of BRD4 degradation for prostate cancer

April 20, 2022

CFT-1946 shows promising efficacy in BRAF-driven cancer models

April 19, 2022

New MAP4K1 inhibitors identified at Shenzhen Ionova Life Science

April 19, 2022

Medshine Discovery presents new PTPN11 inhibitors

April 19, 2022

New Bruton tyrosine kinase inhibitors synthesized at GenFleet Therapeutics

April 19, 2022

Shanghai Ringene Biopharma discovers S-adenosylmethionine synthase isoform type-2 inhibitors

April 19, 2022

Insilico Medicine nominates USP1 small-molecule inhibitor as preclinical candidate

April 14, 2022

NXP-800, orally available HSF1 pathway inhibitor with antitumor activity

April 14, 2022

New TGF-beta receptor type-1 inhibitors identified at Sichuan Kelun-Biotech Biopharmaceutical

April 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...